China Aims To Synchronize With Global Drug Approvals By 2025

 
• By Dexter Jie Yan

China’s new Five-Year Plan for drug quality aims to address hurdles in clinical study ethics committee review while leaving out other restrictions including genetic material export and substandard clinical sites.

China five year plan
China prioritizing synchronized evaluation, review and approval of innovative drugs and medical devices developed elsewhere • Source: Alamy

More from China

More from Asia